tiprankstipranks
Trending News
More News >
Cranswick PLC (GB:CWK)
LSE:CWK
UK Market

Cranswick (CWK) AI Stock Analysis

Compare
36 Followers

Top Page

GB

Cranswick

(LSE:CWK)

Rating:61Neutral
Price Target:
5,423.00p
▲(4.09%Upside)
Cranswick's strong financial performance and positive corporate events are significant strengths. However, technical indicators and valuation concerns weigh on the score, suggesting caution in the short term.
Positive Factors
Acquisitions
Cranswick has announced the acquisition of Blakemans, a leading food-service sausage manufacturer, for £32m.
Earnings
Cranswick's FY25 profit before tax of £197.9m exceeds the range endorsed at its Capital Markets Day and consensus.
Negative Factors
Animal Welfare Concerns
Cranswick shares have dropped 8% following reports of animal cruelty at a farm owned by the company.
Supply Chain Issues
Supermarkets and Cranswick have suspended supplies from Northmoor Farm due to animal welfare concerns.

Cranswick (CWK) vs. iShares MSCI United Kingdom ETF (EWC)

Cranswick Business Overview & Revenue Model

Company DescriptionCranswick plc manufactures and supplies food products to grocery retailers, food service sector, and other food producers in the United Kingdom, Continental Europe, and internationally. The company offers fresh pork, gourmet bacon and gammon, fresh and coated chicken, ready to eat chicken, charcuterie, houmous and dips, and olives and antipasti, gourmet sausages, cooked meats, gourmet pastries, and ingredients, as well as cheeses and pasta. It also offers snacks and sharing boxes under the Bodega brand; olives, olive oil, and pulses under the Cypressa brand; Mediterranean foods under the Ramona's Kitchen brand name; and pet food and supplies under the Vitalin and Alpha Feeds, as well as operates export business. The company was incorporated in 1972 and is based in Hessle, the United Kingdom.
How the Company Makes MoneyCranswick makes money through the production and sale of its high-quality food products. The company's primary revenue streams include the sale of fresh pork and chicken products, as well as a diverse range of value-added products such as sausages, bacon, cooked meats, and gourmet charcuterie. These products are sold to major UK supermarkets, food service providers, and other retailers. A significant portion of Cranswick's revenue is derived from long-term supply agreements and partnerships with leading retail chains, ensuring consistent demand for their products. Additionally, Cranswick invests in expanding its production capacity and enhancing its product offerings to capture a larger market share and meet the evolving preferences of consumers.

Cranswick Financial Statement Overview

Summary
Cranswick has strong revenue growth and profitability metrics, with a solid financial profile supported by a stable balance sheet and robust cash flow generation. Efficient operations and prudent capital management enhance its financial standing.
Income Statement
84
Very Positive
Cranswick demonstrates strong growth in revenue, with a consistent upward trend over the years. The company has managed to maintain a healthy gross profit margin and an improving net profit margin, indicating effective cost management and profitability. EBIT and EBITDA margins are solid, reflecting efficient operations. However, the slight volatility in revenue growth rate needs monitoring.
Balance Sheet
78
Positive
The balance sheet shows a stable financial position with increasing stockholders' equity, indicating retained earnings and strong equity backing. The debt-to-equity ratio remains manageable, reflecting prudent financial leverage. Return on equity is satisfactory, indicating effective utilization of equity. However, the equity ratio suggests a moderately leveraged position, which necessitates careful debt management to maintain stability.
Cash Flow
82
Very Positive
Cranswick's cash flow statements highlight robust operating cash flow, consistently exceeding net income, which reflects strong cash generation capabilities. Free cash flow growth is positive, though some fluctuations in capital expenditures are noted. The operating cash flow to net income ratio is healthy, indicating efficient conversion of earnings to cash. Continued focus on optimizing capital expenditures would enhance free cash flow stability.
BreakdownMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue2.72B2.60B2.32B2.01B1.90B
Gross Profit408.80M376.90M295.70M276.80M265.70M
EBITDA280.70M253.60M220.00M199.00M185.50M
Net Income134.30M113.10M111.40M103.50M92.50M
Balance Sheet
Total Assets1.53B1.38B1.26B1.14B1.04B
Cash, Cash Equivalents and Short-Term Investments5.90M27.00M20.40M200.00K39.90M
Total Debt178.30M127.40M121.70M106.20M131.40M
Total Liabilities543.30M472.50M421.50M373.60M355.00M
Stockholders Equity987.90M911.50M842.90M768.90M686.10M
Cash Flow
Free Cash Flow78.70M127.90M64.10M64.70M109.00M
Operating Cash Flow216.30M228.40M149.20M158.40M180.90M
Investing Cash Flow-160.40M-123.30M-83.80M-130.90M-81.80M
Financing Cash Flow-77.00M-93.40M-45.30M-66.30M-81.60M

Cranswick Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price5210.00
Price Trends
50DMA
5271.80
Negative
100DMA
5105.90
Positive
200DMA
5039.97
Positive
Market Momentum
MACD
-17.31
Positive
RSI
46.13
Neutral
STOCH
25.91
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CWK, the sentiment is Neutral. The current price of 5210 is below the 20-day moving average (MA) of 5268.50, below the 50-day MA of 5271.80, and above the 200-day MA of 5039.97, indicating a neutral trend. The MACD of -17.31 indicates Positive momentum. The RSI at 46.13 is Neutral, neither overbought nor oversold. The STOCH value of 25.91 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:CWK.

Cranswick Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
GBGNC
80
Outperform
£1.01B19.1612.12%0.86%0.49%14.18%
74
Outperform
£1.24B22.409.10%3.30%4.03%3.21%
GBHFG
72
Outperform
£754.86M19.2012.74%5.92%-0.03%7.88%
GBPFD
72
Outperform
£1.65B13.439.02%1.07%1.01%11.12%
67
Neutral
£2.34B37.333.39%5.07%5.40%-67.46%
65
Neutral
$26.82B15.15-4.27%3.17%1.02%1.89%
GBCWK
61
Neutral
£2.79B20.7914.14%0.96%4.77%18.94%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:CWK
Cranswick
5,210.00
695.02
15.39%
GB:HFG
Hilton Food
841.00
-38.07
-4.33%
GB:PFD
Premier Foods
191.80
20.83
12.18%
GB:TATE
Tate & Lyle
517.50
-78.58
-13.18%
GB:GNC
Greencore
232.00
54.92
31.01%
GB:BAKK
Bakkavor Group plc
216.50
68.30
46.09%

Cranswick Corporate Events

Other
Cranswick Director Purchases Shares, Signaling Confidence
Positive
Jul 9, 2025

Cranswick plc has announced a transaction involving the purchase of ordinary shares by Yetunde Hofmann, a director of the company. This transaction, conducted on the London Stock Exchange, reflects internal confidence in the company’s market position and future prospects, potentially influencing stakeholder perceptions positively.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Regulatory Filings and Compliance
Cranswick Announces Total Voting Rights Update
Neutral
Jul 8, 2025

Cranswick plc has announced the total number of ordinary shares in its capital as of July 7, 2025, amounting to 54,262,862, with each share granting one vote. This information is crucial for shareholders to calculate their interests or changes in interests in the company’s share capital under the Financial Conduct Authority’s Disclosure and Transparency Rules.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Other
Cranswick Directors Exercise and Sell Share Options
Neutral
Jul 8, 2025

Cranswick plc, a company involved in the food production sector, announced that four of its directors have exercised and sold share options as part of the company’s Long Term Incentive Plan and Company Share Option Scheme. The directors, Chris Aldersley, Mark Bottomley, Jim Brisby, and Adam Couch, sold portions of their shares at an average price of 5218.3 pence per share. According to the company’s remuneration policy, the remaining vested shares are to be held for two years. This transaction, conducted on the London Stock Exchange, is part of routine financial activities and reflects the directors’ engagement with the company’s incentive schemes.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Other
Cranswick Announces Director-Related Share Transaction
Neutral
Jun 30, 2025

Cranswick plc has disclosed a transaction involving Christie Brisby, the spouse of Director James Robert Brisby, who transferred ordinary shares to him as part of financial planning. This transaction, involving 3,675 shares at a price of 1,800 pence each, was conducted outside a trading venue on June 26, 2025, and reflects internal financial management strategies within the company’s leadership.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Business Operations and StrategyRegulatory Filings and Compliance
Cranswick Director’s Share Transfer Highlights Financial Planning
Neutral
Jun 30, 2025

Cranswick plc announced a transaction involving James Robert Brisby, a director of the company, who transferred ordinary shares from his spouse, Christie Brisby, as part of financial planning. The transaction involved 3,675 shares at a price of 1,800 pence each and took place on June 26, 2025, outside a trading venue. This disclosure highlights the company’s commitment to transparency in its managerial transactions, which could impact stakeholders’ perception of governance and financial planning strategies.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Shareholder MeetingsFinancial DisclosuresRegulatory Filings and Compliance
Cranswick Publishes 2025 Annual Report and AGM Notice
Neutral
Jun 27, 2025

Cranswick plc has released its Annual Report and Financial Statements for 2025 and announced the details of its upcoming Annual General Meeting, scheduled for 28 July 2025. The documents are accessible on the company’s website and through the National Storage Mechanism, reflecting Cranswick’s commitment to transparency and regulatory compliance.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Business Operations and Strategy
Cranswick Director Acquires Shares Under Incentive Plan
Positive
Jun 25, 2025

Cranswick plc announced that Director Christopher Aldersley acquired ordinary shares as ‘Partnership Shares’ under the company’s 2024 Buy As You Earn Share Incentive Plan. This acquisition is part of a regular monthly purchase program, reflecting the company’s ongoing commitment to align management interests with those of shareholders, potentially enhancing stakeholder confidence in the company’s governance and strategic direction.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Other
Cranswick Director Engages in Share Transaction
Neutral
Jun 11, 2025

Cranswick plc announced a transaction involving John Mark Bottomley, a director of the company, who transferred ordinary shares into an ISA. The transaction, conducted on the London Stock Exchange, involved the sale and purchase of shares at 5300 pence each, with a slight difference in volume between the sale and purchase. This notification highlights the ongoing financial activities and transparency within the company’s managerial operations.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Regulatory Filings and Compliance
Cranswick Announces Share Transaction by Director’s Spouse
Neutral
Jun 11, 2025

Cranswick plc announced a transaction involving the transfer of ordinary shares by Tracy Bottomley, the spouse of Director John Mark Bottomley, into an Individual Savings Account (ISA). The transaction, conducted on the London Stock Exchange, involved the sale and purchase of shares at a price of 5300 pence each, with minimal volume difference. This notification underscores the company’s commitment to transparency in financial dealings by its managerial personnel.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Executive/Board ChangesBusiness Operations and Strategy
Cranswick Announces LTIP Awards for Executive Directors
Positive
Jun 3, 2025

Cranswick plc has announced the grant of Long Term Incentive Plan (LTIP) awards to its executive directors. The awards, which are based on a share price of 5290 pence per ordinary share, consist of both Core LTIP Awards and Exceptional Performance LTIP Awards. The vesting of these awards is contingent upon meeting specific performance criteria related to Earnings per Share (EPS), Return on Capital Employed (ROCE), and Total Shareholder Return (TSR). This initiative underscores Cranswick’s commitment to aligning executive incentives with shareholder interests and enhancing company performance.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Regulatory Filings and Compliance
Cranswick Announces Total Voting Rights
Neutral
Jun 2, 2025

Cranswick plc has announced the total number of ordinary shares in its capital as of May 30, 2025, which stands at 54,252,023. Each share carries one vote, and with no shares held in treasury, the total number of voting rights is also 54,252,023. This figure is crucial for shareholders to determine their interest or changes in the share capital under the Financial Conduct Authority’s Disclosure and Transparency Rules.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Business Operations and StrategyRegulatory Filings and Compliance
Cranswick PLC Sees BlackRock Cross 5% Voting Rights Threshold
Neutral
May 27, 2025

Cranswick PLC has announced a change in its shareholder structure, with BlackRock, Inc. crossing a 5% threshold in voting rights as of May 23, 2025. This development indicates a significant shift in the company’s ownership dynamics, potentially impacting its strategic direction and stakeholder interests.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Other
Cranswick Director Acquires Shares Under Incentive Plan
Neutral
May 22, 2025

Cranswick plc announced that Director Christopher Aldersley acquired ordinary shares as ‘Partnership Shares’ under the company’s 2024 Buy As You Earn Share Incentive Plan. This transaction, conducted on the London Stock Exchange, is part of a regular monthly purchase program, reflecting the company’s commitment to aligning management interests with shareholder value.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

M&A TransactionsDividendsBusiness Operations and StrategyFinancial Disclosures
Cranswick Reports Record Revenue and Strategic Growth for 2025
Positive
May 20, 2025

Cranswick plc announced its preliminary results for the 52 weeks ending March 2025, reporting a 4.8% increase in revenue to £2,723.3 million and a 12.1% rise in adjusted profit before tax to £197.9 million. The company highlighted strong growth in its premium product range, with significant contributions from its agricultural operations and strategic acquisitions, such as JSR Genetics and Blakemans. The company also reported a record capital investment of £138 million aimed at expanding capacity and enhancing operational efficiencies. These results underscore Cranswick’s robust market positioning and commitment to long-term growth, benefiting stakeholders through increased dividends and strategic partnerships.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Business Operations and StrategyRegulatory Filings and Compliance
BlackRock Adjusts Voting Rights in Cranswick PLC
Neutral
May 13, 2025

Cranswick PLC, a UK-based company, announced a change in its shareholder structure as BlackRock, Inc., a major asset management firm, has adjusted its voting rights in the company. The notification indicates that BlackRock’s voting rights in Cranswick have fallen below 5%, which could impact the company’s governance and influence in strategic decisions. This adjustment in holdings might affect stakeholders’ perceptions and the company’s market positioning.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Business Operations and StrategyRegulatory Filings and Compliance
BlackRock Increases Stake in Cranswick PLC to 5%
Neutral
May 6, 2025

Cranswick PLC, a UK-based company, has announced a change in its major holdings, with BlackRock, Inc., a significant shareholder, increasing its voting rights to 5% as of May 5, 2025. This development indicates a strategic move by BlackRock, potentially impacting Cranswick’s governance and decision-making processes, reflecting a heightened interest in the company’s future direction.

Business Operations and Strategy
Cranswick Director Acquires Shares Under Incentive Plan
Neutral
Apr 25, 2025

Cranswick plc announced that Director Christopher Aldersley acquired ordinary shares as ‘Partnership Shares’ under the company’s 2024 Buy As You Earn Share Incentive Plan. This acquisition, part of a regular monthly purchase program, also included the awarding of ‘Matching Shares,’ reflecting the company’s ongoing commitment to aligning management interests with shareholder value.

Business Operations and Strategy
Cranswick Director Purchases Shares, Signaling Confidence in Company Growth
Positive
Apr 23, 2025

Cranswick PLC announced a series of transactions involving the purchase of ordinary shares by Rachel Howarth, a Director at the company. These transactions, conducted on the London Stock Exchange, reflect managerial confidence in the company’s performance and strategic direction. The purchases involved a total of 814 shares at varying prices, signaling a positive outlook and potential growth for the company, which could impact stakeholder perceptions and market positioning.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 10, 2025